Michael

Goettler

Group President

Pfizer Inc.

Michael Goettler is the Group President of Pfizer’s Upjohn business and is a member of the Company’s Executive Leadership Team. Previously, Michael was the Global President, Rare Diseases for Pfizer’s Global Innovative Pharma Business.

Michael joined Pfizer through the Wyeth acquisition and was appointed as Regional President, Asia-Pacific for Specialty Care and has held a number of leadership roles across the company including, Global Commercial Officer, Senior Vice President, PIH, and Regional President, Europe for Specialty Care.

Michael is a member of the board of directors of PSI (Population Services International), a global health organization dedicated to improving the health of people in the developing world by focusing on serious global health challenges like family planning, HIV and AIDS, and the greatest threats to children under five, including malaria, diarrhea, pneumonia and malnutrition.

Michael, a native German, studied in Germany, France and the US. He holds an M.B.A. from the University of Texas at Austin and graduated from the Koblenz School of Corporate Management in Germany. Prior to joining Pfizer, Michael worked at Hoechst, Aventis Pharma, and Sanofi.

Latest
Updates

Discover what's happening at PSI

In Memoriam to Bill Gates, Sr.

By Karl Hofmann, President & CEO, PSI  Let me add our voices to those who have paid tribute to Bill Gates, Sr. His remarkable contributions to the work of

+ Read More

Youth Contraceptive Programming: Learning from a Mid-Term Evaluation

As a learning project, PSI’s flagship adolescent sexual and reproductive health program, Adolescents 360 (A360) used its external 2018 mid-term evaluation (MTE) to support corrections

+ Read More

Infected and Affected: The Indirect Consequences of COVID-19 in Central America

By Jennifer Wheeler, PSI Deputy Director, Research, Paola Letona, PSI Evidence Regional Director, LAC, and Sussy Lungo, Regional Executive Director, Asociación PASMO “When you are

+ Read More

Five Market Indicators that Signal the Hormonal IUS will take off

By Kendal Danna, PSI Technical Advisor, Reproductive Health  In 2017, with USAID support, PSI began piloting the introduction of the hormonal Intrauterine System (IUS), also

+ Read More

HIVST for Key populations: Experiences from West Africa, Asia and Southern Africa

More than four decades into the HIV epidemic, an estimated 21% of people with HIV, more than 8.1 million people, remain undiagnosed. HIV self-testing is

+ Read More

In Memoriam of Hildah Mbaya

By Karl Hofmann, President & CEO, Population Services International PSI is extremely sad to report the untimely death of our Country Representative in South Sudan, Hildah

+ Read More